3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Melanoma
2
Lung Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostate Adenocarcinoma
1
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Breast Carcinoma In Situ
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Doxorubicin
4
pazopanib
2
Ifosfamide
2
saracatinib
1
sapanisertib
1
indolepropanol phosphate
1
Watchful Waiting
1
TTI-621
1
Sunitinib
1
Razoxane
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
MLN 8237
1
Imatinib Mesylate
1
HhAntag691
1
Gene Expression Profiling
1
Dexrazoxane
1
Blotting, Western
1
Albumin-Bound Paclitaxel
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Dermatofibrosarcoma
×
Radiation Dose Hypofractionation
×
Clear all
No trials found.